tiprankstipranks
Advertisement
Advertisement
Silence Therapeutics Updates Strategy and siRNA Pipeline
PremiumCompany AnnouncementsSilence Therapeutics Updates Strategy and siRNA Pipeline
27d ago
Silence Therapeutics Shareholders Approve All AGM Resolutions
Premium
Company Announcements
Silence Therapeutics Shareholders Approve All AGM Resolutions
1M ago
Silence Therapeutics Earns Buy Rating on Promising Divesiran Phase I Data and Best-in-Class Potential
Premium
Ratings
Silence Therapeutics Earns Buy Rating on Promising Divesiran Phase I Data and Best-in-Class Potential
1M ago
Buy Rating Reiterated on Silence Therapeutics as Advancing RNAi Pipeline and 2026 Catalysts Support Unchanged $75 Price Target
PremiumRatingsBuy Rating Reiterated on Silence Therapeutics as Advancing RNAi Pipeline and 2026 Catalysts Support Unchanged $75 Price Target
2M ago
Silence Therapeutics Establishes New At-The-Market Program
Premium
Company Announcements
Silence Therapeutics Establishes New At-The-Market Program
2M ago
Silence Therapeutics files $300M ordinary shares offering
Premium
The Fly
Silence Therapeutics files $300M ordinary shares offering
2M ago
Silence Therapeutics Appoints CFO Rhonda Hellums to Board
PremiumCompany AnnouncementsSilence Therapeutics Appoints CFO Rhonda Hellums to Board
7M ago
Silence Therapeutics Announces CEO Departure and Leadership Changes
Premium
Company Announcements
Silence Therapeutics Announces CEO Departure and Leadership Changes
7M ago
Silence Therapeutics CEO Craig Tooman to end employment
Premium
The Fly
Silence Therapeutics CEO Craig Tooman to end employment
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100